{
 "page": "https://insights.moraph.com/compare/health-ai-rules-and-guidance",
 "csv": "https://insights.moraph.com/compare/health-ai-rules-and-guidance.csv",
 "publisher": "Moraph",
 "license": "https://creativecommons.org/licenses/by/4.0/",
 "license_note": "License: CC BY 4.0. Underlying government texts are public domain or under their own terms.",
 "attribution": "Moraph Insights, https://insights.moraph.com/compare/health-ai-rules-and-guidance",
 "slug": "health-ai-rules-and-guidance",
 "title": "AI rules and guidance in US health care: FDA device and decision support guidance, section 1557, ONC certification and Medicare Advantage",
 "sector": "Healthcare",
 "lens": "Data & AI",
 "in_short": "Of the federal instruments on AI in health care compared here, the binding ones are 45 CFR 92.210, which bars discrimination through patient care decision support tools, the ONC decision support certification criterion for certified health IT, and the Medicare Advantage rules on medical necessity determinations. The ONC rule of October 28, 2026 removes the criterion's source attribute ('model card') and risk management requirements from December 28, 2026. FDA's AI-enabled device guidance is still a January 2025 draft, and its clinical decision support guidance, reissued January 29, 2026, is nonbinding. CMS told Medicare Advantage plans in a February 6, 2024 memo that algorithms or AI alone cannot be the basis to deny admission, and in April 2025 it did not finalize proposed AI guardrails.",
 "method": "Each row was read on 2026-11-14 from the issuing body's own text: FDA guidance pages and guidance PDFs and the FDA AI-enabled device list page (fda.gov); the eCFR versioner API for 45 CFR 92.1 and 92.210 and 42 CFR 422.101 as of 2026-11-12; the ONC final rule of October 28, 2026 and the CMS final rule of April 15, 2025 in Federal Register text on govinfo.gov; and CMS's February 6, 2024 HPMS memo, opened from the HPMS memo archive on cms.gov. A Federal Register search on 2026-11-14 of CMS rules and proposed rules since October 2024 mentioning artificial intelligence and Medicare Advantage found no adopted AI-specific Medicare Advantage provision; the Contract Year 2027 final rule of April 6, 2026 (91 FR 17384) mentions AI only in comments and a request for information. Binding means a regulation or certification requirement; guidance and lists are marked as not binding. This table explains the instruments; it is not legal advice.",
 "published": "2026-11-14",
 "last_reviewed": "2026-11-14",
 "columns": [
  {
   "id": "instrument",
   "label": "Instrument"
  },
  {
   "id": "issuer",
   "label": "Issuer"
  },
  {
   "id": "binding",
   "label": "Binding or not"
  },
  {
   "id": "duty",
   "label": "What it requires or says"
  },
  {
   "id": "date",
   "label": "Date"
  }
 ],
 "rows": [
  {
   "id": "fda-ai-device-guidance",
   "cells": {
    "instrument": {
     "text": "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations (docket FDA-2024-D-4488)",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "issuer": {
     "text": "FDA: CDRH, CBER and CDER",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "binding": {
     "text": "Not binding. Draft guidance, marked 'Not for implementation. Contains non-binding recommendations', still listed as draft as checked on November 14, 2026",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "duty": {
     "text": "Recommends what marketing submissions for devices with AI-enabled software functions should contain, and proposes recommendations on design, development and implementation across the total product life cycle",
     "source": "s1",
     "checked": "2026-11-14"
    },
    "date": {
     "text": "Draft issued January 7, 2025; page content current as of January 7, 2025",
     "source": "s1",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "fda-ai-device-list",
   "cells": {
    "instrument": {
     "text": "List of Artificial Intelligence-Enabled Medical Devices",
     "source": "s2",
     "checked": "2026-11-14"
    },
    "issuer": {
     "text": "FDA",
     "source": "s2",
     "checked": "2026-11-14"
    },
    "binding": {
     "text": "Not a rule. A public list of AI-enabled devices authorized for marketing in the United States; FDA says it is not comprehensive",
     "source": "s2",
     "checked": "2026-11-14"
    },
    "duty": {
     "text": "None. Devices are identified mainly by AI-related terms in their authorization summaries or classification; FDA encourages sponsors to include information in public summaries so devices with LLM-based functions can be identified in a future update",
     "source": "s2",
     "checked": "2026-11-14"
    },
    "date": {
     "text": "Page content current as of September 4, 2026; newest final decision date on the list June 29, 2026; updated periodically",
     "source": "s2",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "fda-cds-guidance",
   "cells": {
    "instrument": {
     "text": "Clinical Decision Support Software, final guidance (docket FDA-2017-D-6569)",
     "source": "s3",
     "checked": "2026-11-14"
    },
    "issuer": {
     "text": "FDA: CDRH, CBER and CDER",
     "source": "s3",
     "checked": "2026-11-14"
    },
    "binding": {
     "text": "Not binding. Final guidance headed 'Contains Nonbinding Recommendations'; it does not establish rights and is not binding on FDA or the public",
     "source": "s4",
     "checked": "2026-11-14"
    },
    "duty": {
     "text": "Explains which clinical decision support software functions fall outside the device definition: a function must meet all four criteria in FD&C Act section 520(o)(1)(E), including enabling the health care professional to independently review the basis for its recommendations so that the professional does not rely primarily on them",
     "source": "s4",
     "checked": "2026-11-14"
    },
    "date": {
     "text": "Issued January 29, 2026, superseding the version issued January 6, 2026",
     "source": "s4",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "hhs-92-210",
   "cells": {
    "instrument": {
     "text": "45 CFR 92.210, nondiscrimination in the use of patient care decision support tools (section 1557 rule)",
     "source": "s5",
     "checked": "2026-11-14"
    },
    "issuer": {
     "text": "HHS",
     "source": "s5",
     "checked": "2026-11-14"
    },
    "binding": {
     "text": "Binding regulation",
     "source": "s5",
     "checked": "2026-11-14"
    },
    "duty": {
     "text": "Covered entities must not discriminate on the basis of race, color, national origin, sex, age or disability through patient care decision support tools; they have an ongoing duty to make reasonable efforts to identify tools that use those factors as input variables, and must make reasonable efforts to mitigate the risk of discrimination from each one identified",
     "source": "s5",
     "checked": "2026-11-14"
    },
    "date": {
     "text": "Part 92 effective July 5, 2024; paragraphs (b) and (c) must be met within 300 days of July 5, 2024",
     "source": "s6",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "onc-dsi-criterion",
   "cells": {
    "instrument": {
     "text": "Decision support interventions certification criterion, 45 CFR 170.315(b)(11), as revised by the ONC final rule of October 28, 2026 (91 FR 67916)",
     "source": "s7",
     "checked": "2026-11-14"
    },
    "issuer": {
     "text": "ONC, HHS",
     "source": "s7",
     "checked": "2026-11-14"
    },
    "binding": {
     "text": "Binding on health IT developers whose Health IT Modules are certified to this criterion in the ONC Health IT Certification Program; kept in revised form",
     "source": "s7",
     "checked": "2026-11-14"
    },
    "duty": {
     "text": "Kept, in revised form: support for users selecting evidence-based and predictive decision support interventions. Removed: source attribute support, source attribute access and modification, and intervention risk management (paragraphs (b)(11)(iv) to (vi))",
     "source": "s7",
     "checked": "2026-11-14"
    },
    "date": {
     "text": "Published October 28, 2026; the amendment to 170.315 takes effect December 28, 2026",
     "source": "s7",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "cms-ma-42-cfr-422-101",
   "cells": {
    "instrument": {
     "text": "42 CFR 422.101(b)(6) and (c)(1), Medicare Advantage coverage criteria and medical necessity determinations",
     "source": "s8",
     "checked": "2026-11-14"
    },
    "issuer": {
     "text": "CMS",
     "source": "s8",
     "checked": "2026-11-14"
    },
    "binding": {
     "text": "Binding regulation",
     "source": "s8",
     "checked": "2026-11-14"
    },
    "duty": {
     "text": "MA organizations must base medical necessity determinations on Medicare coverage and benefit criteria, whether services are reasonable and necessary, and the enrollee's medical history, physician recommendations and clinical notes. Internal coverage criteria are allowed only where Medicare criteria are not fully established, must rest on current evidence, and must be posted publicly with their evidence and rationale",
     "source": "s8",
     "checked": "2026-11-14"
    },
    "date": {
     "text": "Text as in the eCFR on November 12, 2026; CMS's February 6, 2024 FAQ says these provisions apply to coverage beginning January 1, 2024",
     "source": "s9",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "cms-ma-ai-faq",
   "cells": {
    "instrument": {
     "text": "HPMS memo, Frequently Asked Questions related to Coverage Criteria and Utilization Management Requirements in CMS Final Rule (CMS-4201-F), question 2",
     "source": "s9",
     "checked": "2026-11-14"
    },
    "issuer": {
     "text": "CMS",
     "source": "s9",
     "checked": "2026-11-14"
    },
    "binding": {
     "text": "Guidance to MA organizations and Medicare-Medicaid Plans explaining the binding rules in 42 CFR 422.101",
     "source": "s9",
     "checked": "2026-11-14"
    },
    "duty": {
     "text": "An algorithm or software tool can assist coverage decisions, but the MA organization must make sure it follows all applicable rules, including 422.101(c). Algorithms or AI alone cannot be the basis to deny admission or downgrade to an observation stay; AI cannot be used to shift posted coverage criteria over time; plans should check tools for bias before use",
     "source": "s9",
     "checked": "2026-11-14"
    },
    "date": {
     "text": "Issued February 6, 2024",
     "source": "s9",
     "checked": "2026-11-14"
    }
   }
  },
  {
   "id": "cms-ma-ai-guardrails",
   "cells": {
    "instrument": {
     "text": "Proposed 'Ensuring Equitable Access to Medicare Advantage Services: Guardrails for Artificial Intelligence' in the Contract Year 2026 Medicare Advantage and Part D rule",
     "source": "s10",
     "checked": "2026-11-14"
    },
    "issuer": {
     "text": "CMS",
     "source": "s10",
     "checked": "2026-11-14"
    },
    "binding": {
     "text": "Not adopted. The final rule says CMS does not intend to finalize it and will consider whether future rulemaking on AI is appropriate",
     "source": "s10",
     "checked": "2026-11-14"
    },
    "duty": {
     "text": "None in force from this proposal",
     "source": "s10",
     "checked": "2026-11-14"
    },
    "date": {
     "text": "Final rule published April 15, 2025 (90 FR 15792)",
     "source": "s10",
     "checked": "2026-11-14"
    }
   }
  }
 ],
 "sources": [
  {
   "id": "s1",
   "title": "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations, draft guidance (guidance page and draft PDF)",
   "publisher": "U.S. Food and Drug Administration",
   "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/artificial-intelligence-enabled-device-software-functions-lifecycle-management-and-marketing",
   "checked": "2026-11-14"
  },
  {
   "id": "s2",
   "title": "List of Artificial Intelligence-Enabled Medical Devices",
   "publisher": "U.S. Food and Drug Administration",
   "url": "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices",
   "checked": "2026-11-14"
  },
  {
   "id": "s3",
   "title": "Clinical Decision Support Software, guidance page",
   "publisher": "U.S. Food and Drug Administration",
   "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software",
   "checked": "2026-11-14"
  },
  {
   "id": "s4",
   "title": "Clinical Decision Support Software, Guidance for Industry and Food and Drug Administration Staff (January 29, 2026), PDF",
   "publisher": "U.S. Food and Drug Administration",
   "url": "https://www.fda.gov/media/109618/download",
   "checked": "2026-11-14"
  },
  {
   "id": "s5",
   "title": "45 CFR 92.210, Nondiscrimination in the use of patient care decision support tools",
   "publisher": "U.S. Department of Health and Human Services (eCFR)",
   "url": "https://www.ecfr.gov/current/title-45/part-92/section-92.210",
   "checked": "2026-11-14"
  },
  {
   "id": "s6",
   "title": "45 CFR 92.1, Purpose and effective date",
   "publisher": "U.S. Department of Health and Human Services (eCFR)",
   "url": "https://www.ecfr.gov/current/title-45/part-92/section-92.1",
   "checked": "2026-11-14"
  },
  {
   "id": "s7",
   "title": "Health Data, Technology, and Interoperability: ONC Deregulatory Actions To Unleash Prosperity, final rule (91 FR 67916, October 28, 2026): DATES, section III.A.2.e and amendatory instruction 11",
   "publisher": "Office of the National Coordinator for Health Information Technology, HHS",
   "url": "https://www.govinfo.gov/content/pkg/FR-2026-10-28/html/2026-21943.htm",
   "checked": "2026-11-14"
  },
  {
   "id": "s8",
   "title": "42 CFR 422.101, Requirements relating to basic benefits",
   "publisher": "Centers for Medicare & Medicaid Services (eCFR)",
   "url": "https://www.ecfr.gov/current/title-42/section-422.101",
   "checked": "2026-11-14"
  },
  {
   "id": "s9",
   "title": "HPMS memo of February 6, 2024, Frequently Asked Questions related to Coverage Criteria and Utilization Management Requirements in CMS Final Rule (CMS-4201-F), in HPMS Memos for week 2, February 5-9, 2024",
   "publisher": "Centers for Medicare & Medicaid Services",
   "url": "https://www.cms.gov/about-cms/information-systems/hpms/hpms-memos-archive-weekly/hpms-memos-wk-2-february-5-9",
   "checked": "2026-11-14"
  },
  {
   "id": "s10",
   "title": "Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, final rule (90 FR 15792, April 15, 2025)",
   "publisher": "Centers for Medicare & Medicaid Services",
   "url": "https://www.govinfo.gov/content/pkg/FR-2025-04-15/html/2025-06008.htm",
   "checked": "2026-11-14"
  }
 ],
 "omitted": [
  {
   "where": "hhs-92-210/date",
   "reason": "The eCFR states the 92.210(b) and (c) compliance date only as within 300 days of July 5, 2024; no calendar date is given here because none was read in a source."
  },
  {
   "where": "cms-ma-ai-faq/binding",
   "reason": "No CMS notice withdrawing or replacing the February 6, 2024 FAQ was found, but its current status was not confirmed beyond its place in the HPMS memo archive."
  },
  {
   "where": "cms-ma-42-cfr-422-566",
   "reason": "42 CFR 422.566(d), physician or other appropriate professional review before an adverse medical necessity decision, was opened but left out: it does not mention algorithms or AI."
  }
 ]
}
